FDA and industry reach agreement in principle on medical device user fees

The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program. The recommendations would authorize the FDA to collect $595 million in user fees over five years, plus adjustments for inflation. Details of the agreement, such as the fee structure, are expected to be finalized soon.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm289828.htm